MedElevator Войти в исследования
← Поиск публикаций

DOI 10.36518/2689-0216.1040

Медицинская библиотека · HCA healthcare journal of medicine · 2020

Perampanel-Induced Cataplexy in a Young Male with Generalized Epilepsy.

Kenaan Kelsey, Zafar Mohsin, Bond Ronnie, Gracious Barbara L

Клинический случайСтатьяПеревод в очереди

Аннотация

Description Perampanel (Fycompa) is a newer anti-epileptic drug believed to exert its effects in the central nervous system by inhibiting post-synaptic glutamate receptors. However, the precise therapeutic mechanism is unknown. The most common neuropsychiatric side effect is affective dysregulation; there are also reports of psychosis. We describe a 32 year old African American male with recurring generalized tonic-clonic (GTC) seizures, who presented to our hospital with onset of mood lability for several months, after Perampanel was added to his antiepileptic medications. Perampanel administration was temporarily withheld, and subsequently on restarting, noted to be coincident with neuropsychiatric symptomatology, including motor weakness in emotional contexts. The mechanisms underlying cataplexy are complex and, in our patient, most likely induced by an interaction between Perampanel and the wakeful inhibition of the sublaterodorsal nucleus projections.

Для цитирования: Kenaan Kelsey, Zafar Mohsin, Bond Ronnie, Gracious Barbara L. Perampanel-Induced Cataplexy in a Young Male with Generalized Epilepsy.. HCA healthcare journal of medicine. 2020. DOI: 10.36518/2689-0216.1040.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.